500
Participants
Start Date
May 31, 2002
Primary Completion Date
November 30, 2003
Study Completion Date
November 30, 2003
ipratropium plus salbutamol UDV
salbutamol UDV
Philippine Children's Medical Center, Quezon
Jose Reyes Memorial Medical Center, Manila
Philippine General Hospital, Manila
Amang Rodriguez Hospital, Marikina City
San Juan de Dios Hospital, Pasay
Rizal Provincial Hospital, Pasig
Quezon City General Hospital, Quezon
East Ave Medical Center, Quezon City
Philipines Heart Center, Quezon City
Quirino Memorial Medical Center, Quezon City
Lead Sponsor
Boehringer Ingelheim
INDUSTRY